Home

envoi froissé tas chmp meeting minutes soir la chronique Observatoire

Frankie1x (@Frankie1x2) / Twitter
Frankie1x (@Frankie1x2) / Twitter

CHMP meeting highlights – July 2022 - European Pharmaceutical Review
CHMP meeting highlights – July 2022 - European Pharmaceutical Review

Comparison of regulatory pathways for the approval of advanced therapies in  the European Union and the United States - Cytotherapy
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States - Cytotherapy

Institutionnalisation du médiateur européen et nouveaux instruments  d'enquête : le cas de l'enquête de 2017-2019 sur l'agence européenne des  médicaments | Cairn.info
Institutionnalisation du médiateur européen et nouveaux instruments d'enquête : le cas de l'enquête de 2017-2019 sur l'agence européenne des médicaments | Cairn.info

The European Medicines Agency (EMA) grants positive opinion for  subcutaneous daratumumab in frontline and relapsed/refractory se
The European Medicines Agency (EMA) grants positive opinion for subcutaneous daratumumab in frontline and relapsed/refractory se

Sensors | Free Full-Text | Toward a Regulatory Qualification of Real-World  Mobility Performance Biomarkers in Parkinson's Patients Using Digital  Mobility Outcomes
Sensors | Free Full-Text | Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson's Patients Using Digital Mobility Outcomes

GlaxoSmithKline's Juluca, Amgen's Repatha and more score EU backing in busy  week for CHMP | Fierce Pharma
GlaxoSmithKline's Juluca, Amgen's Repatha and more score EU backing in busy week for CHMP | Fierce Pharma

The EU Scientific Advice Process: Roadmap for Clinical Development Success
The EU Scientific Advice Process: Roadmap for Clinical Development Success

Beach Volley Meeting BVG Camp
Beach Volley Meeting BVG Camp

Unlocking the EMA Meetings: the Process and How to Prepare Adequately |  Voisin Consulting Life Sciences
Unlocking the EMA Meetings: the Process and How to Prepare Adequately | Voisin Consulting Life Sciences

Our Involvement in the CHMP - Paul-Ehrlich-Institut
Our Involvement in the CHMP - Paul-Ehrlich-Institut

New | CENTRALISED PROCEDURE PROCESS
New | CENTRALISED PROCEDURE PROCESS

Committee for medicinal products for human use (CHMP)
Committee for medicinal products for human use (CHMP)

Daniele Focosi, MD PhD MSc on Twitter: "Another failure for molnupiravir….  ⁦@theosanderson⁩ ⁦@PeacockFlu⁩ ⁦@LongDesertTrain⁩ ⁦@OliasDave⁩  ⁦@siamosolocani⁩ ⁦@ACasadevall1⁩ https://t.co/03A0Ipd8Cc" / Twitter
Daniele Focosi, MD PhD MSc on Twitter: "Another failure for molnupiravir…. ⁦@theosanderson⁩ ⁦@PeacockFlu⁩ ⁦@LongDesertTrain⁩ ⁦@OliasDave⁩ ⁦@siamosolocani⁩ ⁦@ACasadevall1⁩ https://t.co/03A0Ipd8Cc" / Twitter

Committee for medicinal products for human use (CHMP)
Committee for medicinal products for human use (CHMP)

2021 New Drug Approvals: Review of FDA and EMA Marketing Authorisations
2021 New Drug Approvals: Review of FDA and EMA Marketing Authorisations

5-minute weekly newscast – 02/06/2019 - MD Pharma Consulting Group
5-minute weekly newscast – 02/06/2019 - MD Pharma Consulting Group

Company internal activities and timelines leading to October 2014 SEED... |  Download Table
Company internal activities and timelines leading to October 2014 SEED... | Download Table

Fffffffffff7F7
Fffffffffff7F7

Planned for March 2023
Planned for March 2023

Pharmya
Pharmya

SERB reçoit un avis favorable du CHMP pour l'utilisation de Voraxaze®  (glucarpidase) en tant que traitement d'urgence de la toxicité du  méthotrexate liée à un retard d'élimination
SERB reçoit un avis favorable du CHMP pour l'utilisation de Voraxaze® (glucarpidase) en tant que traitement d'urgence de la toxicité du méthotrexate liée à un retard d'élimination

Table of 12 included requests in chronological order | Download Table
Table of 12 included requests in chronological order | Download Table

CHMP meeting highlights - February 2023
CHMP meeting highlights - February 2023

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron  BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union |  Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union | Business Wire

Pink Sheet: How To Win Over The EU CHMP At Virtual Meetings | 3D  Communications
Pink Sheet: How To Win Over The EU CHMP At Virtual Meetings | 3D Communications

Byways Committee Meeting – BigSurKate
Byways Committee Meeting – BigSurKate

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the  Submission of a Marketing Authorization Application to the European  Medicines Agency for PRX-102 for the Treatment of Fabry Disease
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the Submission of a Marketing Authorization Application to the European Medicines Agency for PRX-102 for the Treatment of Fabry Disease